High molecular weight amyloid β1‐42 oligomers induce neurotoxicity via plasma membrane damage

Amyloid β‐protein (Aβ) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, high MW (HMW) aggregates such as protofibrils, and ultimately fibrils. These Aβ species can generally form amyloid plaques implicated in the neurodegeneration of Alzheimer disease (AD), but therapies designed to reduce plaque load have not demonstrated clinical efficacy. Recent evidence implicates amyloid oligomers in AD neuropathology, but the precise mechanisms are uncertain. We examined the mechanisms of neuronal dysfunction from HMW‐Aβ1‐42 exposure by measuring membrane integrity, reactive oxygen species (ROS) generation, membrane lipid peroxidation, membrane fluidity, intracellular calcium regulation, passive membrane electrophysiological properties, and long‐term potentiation (LTP). HMW‐Aβ1‐42 disturbed membrane integrity by inducing ROS generation and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation, depolarization, and impaired LTP. The damaging effects of HMW‐Aβ1‐42 were significantly greater than those of LMW‐Aβ1‐42 Therapeutic reduction of HMW‐Aβ1‐42 may prevent AD progression by ameliorating direct neuronal membrane damage.—Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., Ono, K. High molecular weight amyloid β1‐42 oligomers induce neurotoxicity via plasma membrane damage. FASEB J. 33, 9220–9234 (2019). www.fasebj.org

[1]  Christian Peters,et al.  Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword , 2018, Front. Aging Neurosci..

[2]  T. Kálai,et al.  A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta , 2018, Molecules.

[3]  P. Palumaa,et al.  In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells , 2017, PloS one.

[4]  M. Tomás,et al.  Oxidative stress and the amyloid beta peptide in Alzheimer’s disease , 2017, Redox biology.

[5]  K. Ono Alzheimer's disease as oligomeropathy , 2017, Neurochemistry International.

[6]  Z. Leonenko,et al.  Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease , 2017, PloS one.

[7]  Z. Khachaturian,et al.  Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.

[8]  J. H. Viles,et al.  Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes* , 2016, The Journal of Biological Chemistry.

[9]  K. Kawakami,et al.  Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons , 2016, Scientific Reports.

[10]  M. Gairí,et al.  Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments , 2016, Proceedings of the National Academy of Sciences.

[11]  C. Dobson,et al.  Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells , 2016, Scientific Reports.

[12]  Kenjiro Ono,et al.  High-speed atomic force microscopy reveals structural dynamics of amyloid Β1-42 aggregates , 2016, Journal of the Neurological Sciences.

[13]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[14]  C. Masters,et al.  Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons* , 2015, The Journal of Biological Chemistry.

[15]  A. Bogaerts,et al.  Effect of lipid peroxidation on membrane permeability of cancer and normal cells subjected to oxidative stress , 2015, Chemical science.

[16]  James C. Lee,et al.  Role of membrane biophysics in Alzheimer's–related cell pathways , 2015, Front. Neurosci..

[17]  R. Nussinov,et al.  Role of the Fast Kinetics of Pyroglutamate-Modified Amyloid-β Oligomers in Membrane Binding and Membrane Permeability , 2014, Biochemistry.

[18]  A. Milelli,et al.  Oxidative stress in Alzheimer's disease: are we connecting the dots? , 2014, Journal of medicinal chemistry.

[19]  J. Renger,et al.  A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid , 2014, The Journal of Neuroscience.

[20]  Shinya Yamanaka,et al.  A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells , 2014, Scientific Reports.

[21]  M. Pohanka Alzheimer´s disease and oxidative stress: a review. , 2013, Current medicinal chemistry.

[22]  B. Hyman,et al.  Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  S. Maiti,et al.  Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers , 2013, Front. Physiol..

[24]  R. Nussinov,et al.  Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane. , 2013, Journal of chemical theory and computation.

[25]  Florentina Tofoleanu,et al.  Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes. , 2012, Journal of molecular biology.

[26]  W. Markesbery,et al.  Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression , 2012, Neurobiology of Aging.

[27]  Toshio Ando,et al.  Guide to video recording of structure dynamics and dynamic processes of proteins by high-speed atomic force microscopy , 2012, Nature Protocols.

[28]  Hans-Ulrich Demuth,et al.  Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.

[29]  H. Nishijo,et al.  Phenolic compounds prevent beta-amyloid-protein oligomerization and synaptic dysfunction by site-specific binding , 2012, Alzheimer's & Dementia.

[30]  H. Qing,et al.  Calcium channel blockers and Alzheimer's disease , 2012, Neural regeneration research.

[31]  I. Parker,et al.  Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.

[32]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[33]  D. Cribbs,et al.  Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1 , 2011, Alzheimer's & Dementia.

[34]  K. Matsuzaki,et al.  Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. , 2011, Biochemistry.

[35]  E. Klann,et al.  Reactive oxygen species in the regulation of synaptic plasticity and memory. , 2011, Antioxidants & redox signaling.

[36]  D. Teplow,et al.  Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid β-Protein Assembly and Toxicity* , 2010, The Journal of Biological Chemistry.

[37]  I. Bezprozvanny,et al.  The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.

[38]  S. Scheff,et al.  Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex , 2010, Journal of neuropathology and experimental neurology.

[39]  P. Faller,et al.  Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. , 2009, Biochimie.

[40]  D. Teplow,et al.  Structure-neurotoxicity relationships of amyloid β-protein oligomers , 2009, Neuroscience Research.

[41]  M. Berridge Calcium signalling in health and disease. , 2009, Biochemical and biophysical research communications.

[42]  Weiming Xia,et al.  A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. , 2009, Archives of neurology.

[43]  D. Walsh,et al.  Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases , 2008, Molecular medicine.

[44]  Grace E. Stutzmann The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[45]  M. Sakakibara,et al.  Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats , 2007, Neurobiology of Aging.

[46]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[47]  W. Gattaz,et al.  Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus , 2005, Journal of Neural Transmission.

[48]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[49]  Roger Anwyl,et al.  Synaptic plasticity in animal models of early Alzheimer's disease. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[50]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[52]  C. Yip,et al.  Aβ42-Peptide Assembly on Lipid Bilayers , 2002 .

[53]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[54]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[55]  T. Ando,et al.  A high-speed atomic force microscope for studying biological macromolecules , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[57]  And J. Sklansky,et al.  Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. , 2000, Biochemistry.

[58]  E. Niki,et al.  A novel fluorescent probe diphenyl‐1‐pyrenylphosphine to follow lipid peroxidation in cell membranes , 2000 .

[59]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[60]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[61]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[62]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[63]  C. Finch,et al.  Evidence for Apoptotic Cell Death in Alzheimer's Disease , 1995, Experimental Neurology.

[64]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  K. Ono,et al.  High-Speed Atomic Force Microscopy of Individual Amyloidogenic Protein Assemblies. , 2018, Methods in molecular biology.

[66]  Brian J. Wiltgen,et al.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-b , 2012 .

[67]  I. Parker,et al.  Single-channel Ca 2+ imaging implicates A  1–42 amyloid pores in Alzheimer’s disease pathology , 2011 .

[68]  N. Arispe Architecture of the Alzheimer’s AβP Ion Channel Pore , 2003, The Journal of Membrane Biology.

[69]  C. Yip,et al.  Abeta42-peptide assembly on lipid bilayers. , 2002, Journal of molecular biology.

[70]  M. Kirkitadze,et al.  Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. , 2002 .

[71]  N. Noguchia,et al.  A novel fluorescent probe diphenyl-1-pyrenylphosphine to follow lipid peroxidation in cell membranes. , 2000, FEBS letters.